ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Transderm Scop (Details) - Transderm Scop $ in Millions |
Mar. 31, 2021
USD ($)
|
|---|---|
| Acquisitions And Collaborations [Line Items] | |
| Purchase price | $ 60 |
| Contingent Consideration | 24 |
| Consideration transferred | $ 84 |
| X | ||||||||||
- Definition Acquisitions and collaborations. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|